CROPS NEWS
Wed Jan 30, 2013 10:46 AM CST

(Dow Jones) -- Monsanto Co. has bought assets from a California-based company that uses microbes to improve crop production.

Monsanto also said that it made an equity investment in Synthetic Genomics Inc. and that the two companies reached a multiyear agricultural research agreement

The purchase of assets from Agradis, which Synthetic Genomics co-founded in 2011, includes the collection of microbes as well as the company's name. Terms of the deal weren't disclosed.

The assets build upon Monsanto's agricultural biological platform, called BioDirect, launched last year. Agricultural biologicals generally refer to seed or crop treatments derived from natural materials.

Agradis has ...

Quick View
  • The New Dicamba At an event exhibiting the company's soon-to-arrive Dicamba-tolerant soybean trait, Monsanto repr...
  • Rates Too Low Too Long Discounted interest rates have led to unintended consequences in land values, a shortage of funds...
  • Center Pivots Take a Beating Severe storms in mid-June have damaged hundreds of center pivot irrigation systems in Nebraska al...
  • "Easy Money Times Over" Feeding the world population won't be as hard as expected over the next decade some experts forec...
  • A Hunger for High-Tech The Gruhlkey brothers of Wildorado, Texas, are using technology and thoughtful cropping choices t...
  • Clearing the Air EPA Administrator Gina McCarthy told a group of agribusiness representatives that her agency want...
  • No More Outlaw Vets Veterinarians can start breathing a little easier now when they go to work, without the fear that...
  • Ask the Vet My vet diagnosed anaplaz and I've never heard of that.
Related News Stories
Shaw: Under the Agridome
Shaw: Under the Agridome
Shaw: Under the Agridome
Dicamba Delays
Shaw: Under the Agridome
Brazil Non-GE Soy Boom Stalls
Shaw: Under the Agridome
Clinton Backs Biotechnology
Shaw: Under the Agridome
Oregon Eyes GMO Field Mapping